Navigation Links
Pulmonary/ Respiratory Drug Delivery Market by Formulation, Device Type, Canister, End User, Applications - Forecasts to 2021
Date:2/28/2017

NEW YORK, Feb. 27, 2017 /PRNewswire/ -- Pulmonary drug delivery market is projected to reach USD 52.37 billion by 2021 from USD 36.10 billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing preference of pulmonary route as an alternate route of drug delivery, rising focus on the development of smart/digital inhalers and increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis is expected to drive the market growth during the forecast period. However, emerging markets and growth in online marketing channel offers opportunities for the market.


Read the full report: http://www.reportlinker.com/p04724242-summary/view-report.html


The pulmonary drug delivery market is segmented based on formulations, canister type, applications, end users, and regions.

Based on canister type, the market is segmented into plain canister and coated canister. The coated canister segment is expected to witness the highest growth during the forecast period due to various advantages such as robust profile for filling, avoiding crimping, and withstanding the pressure associated with the type of propellant (HFAs or CFCs), minimizing formulation and canister interactions and avoids deposition of HFA on the canister surface.

Based on applications, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory therapy, and treatment of patients on ventilators). The asthma segment is expected to witness the highest growth during the forecast period due to increasing prevalence of asthma across the globe.

Based on the end user, the market is segmented into hospitals & clinics and homecare settings. Homecare settings is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to technological advancements in pulmonary drug delivery devices that enable their use in the home care settings. Digital inhalers allow patients to maintain medical records and dosage of the drug administered; this also enable patients to share this record with physicians.

Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing aging population, increasing adoption of an unhealthy lifestyle, increasing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region. Presently, North America is expected to dominate the market. This is due to increasing technological developments, increasing prevalence of chronic respiratory and supportive reimbursement policies in the form of Medicare and Medicaid

The key players in the pulmonary drug delivery market focus on various organic and inorganic growth strategies such as agreements, collaborations, expansions, product launches & approvals, and partnerships.

The key players in this market are Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

Apart from the comprehensive geographical analysis, product analysis, and market sizing the report also provides a competitive landscape that covers the growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change in strategic approach, and R&D investments for innovations in products and technologies, and levels of output to remain successful.


Research Coverage:
The report defines, describes, and forecasts the pulmonary drug delivery market on the basis of formulations, canister type, application, end user, and regions. It provides detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as acquisitions, product developments, and expansions in the pulmonary drug delivery market across four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).


Reasons to buy the report:
The report on "Pulmonary Drug Delivery" provides quantitative information for clients seeking market size information on various segments of the pulmonary drug delivery market.
This report also provides access to the quantitative data on pulmonary drug delivery market. This report covers –
- Current and forecast assessment of the global pulmonary drug delivery market
- Country-wise assessment of each of the segments
- Global market share analysis of major segments of the pulmonary drug delivery market
- Adoption trends of pulmonary drug delivery in major geographic segments
- Five-year coverage of strategic developments of top players in the pulmonary drug delivery market
- Product portfolio mapping of leading players in the pulmonary drug delivery market
`
Read the full report: http://www.reportlinker.com/p04724242-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pulmonary-respiratory-drug-delivery-market-by-formulation-device-type-canister-end-user-applications---forecasts-to-2021-300414530.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Pulmonary/Respiratory Drug Delivery Market Worth 52.37 Billion USD by 2021
2. New Study Published in Lancet Respiratory Medicine Highlights QIAGENs QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants
3. Global Respiratory Care Devices Market Expected to Reach $21,300 Million by 2022 - Allied Market Research
4. Pulmonary Drug Delivery Devices Market to Reach US$43.05 Billion by 2024: Rising Prevalence of Respiratory Disorders to Drive Growth, Notes TMR
5. Respiratory Care Devices Market Worth 24.07 Billion USD by 2021
6. Oral Topical Formulation, ARMS-I, Provides Protection Against Upper Respiratory Infections as well as Reducing Severity and Duration of Cold
7. Anne Whitaker Named CEO of KNOW Bio Respiratory Company
8. Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025
9. Linde Completes Acquisition of The Service Center, Supplier of Medical Oxygen and Respiratory Equipment Repair Services
10. Research and Markets - Global Respiratory Disposable Devices Market Growth of 5%, 2016-2020 With Ambu, Smiths Medical & Teleflex Dominating
11. Research and Markets - Global Respiratory Diagnostics Market Value of USD 7.45 Billion by 2021 - Trends, Technologies & Opportunities Report 2016-2021 - Vendors: Seegene, Cosmed, Alere
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... International plc (NASDAQ: ENDP ) will announce its second-quarter ... senior management team will host a conference call and webcast before ... The dial-in number to access the call is U.S./ ... is 45397076. Please dial in 10 minutes prior to the scheduled ... of the call will be available from August 8, 2017 at ...
(Date:7/12/2017)... 2017 CarpalAID is a revolutionary new product that relieves ... Carpal tunnel syndrome affects more than 8 million people a ... of men. The common methods of treating CTS are painful surgery, ... braces or gloves. ... CarpalAID is a clear patch worn on the palm ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, Inc., ... diagnostic testing equipment as well as middleware information ... way to make quality assurance easier and more ... is well known for the innovation that it ... Monitor elevates quality assurance processes to a new ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... ChenMed , a leading provider of value-based care for seniors, today announced ... Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine at the ... for the UVA Health System, brings 30 years of highly relevant experience to his ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced ... its existing adherence automation lines. The ATP® Mini and InspectRx® Mini ... TCG’s standard products, but at a size and price point that can help ...
(Date:7/20/2017)... ... July 20, 2017 , ... A budget proposal to switch ... of - living - adjustment (COLA) is a bad deal for older and disabled ... price index (CPI) would grow even more slowly than the conventional one that is ...
Breaking Medicine News(10 mins):